HomeCompareALPN vs PEP

ALPN vs PEP: Dividend Comparison 2026

ALPN yields 3.08% · PEP yields 3.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $120.3K in total portfolio value· pulled ahead in Year 3
10 years
ALPN
ALPN
● Live price
3.08%
Share price
$64.97
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.4K
Annual income
$375.35
Full ALPN calculator →
PEP
PepsiCo Inc.
● Live price
3.66%
Share price
$155.29
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$144.7K
Annual income
$63,430.49
Full PEP calculator →

Portfolio growth — ALPN vs PEP

📍 PEP pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALPNPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALPN + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALPN pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALPN
Annual income on $10K today (after 15% tax)
$261.66/yr
After 10yr DRIP, annual income (after tax)
$319.05/yr
PEP
Annual income on $10K today (after 15% tax)
$311.45/yr
After 10yr DRIP, annual income (after tax)
$53,915.92/yr
At 15% tax rate, PEP beats the other by $53,596.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALPN + PEP for your $10,000?

ALPN: 50%PEP: 50%
100% PEP50/50100% ALPN
Portfolio after 10yr
$84.5K
Annual income
$31,902.92/yr
Blended yield
37.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

ALPN
Analyst Ratings
9
Buy
6
Hold
Consensus: Buy
Price Target
$55.00
-15.3% upside vs current
Range: $44.00 — $65.00
Altman Z
65.0
Piotroski
3/9
PEP
Analyst Ratings
1
Strong
15
Buy
28
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+11.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALPN buys
0
PEP buys
0
No recent congressional trades found for ALPN or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALPNPEP
Forward yield3.08%3.66%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$24.4K$144.7K
Annual income after 10y$375.35$63,430.49
Total dividends collected$3.4K$125.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$55.00$172.43

Year-by-year: ALPN vs PEP ($10,000, DRIP)

YearALPN PortfolioALPN Income/yrPEP PortfolioPEP Income/yrGap
1$11,008$307.83$10,854$514.44+$154.00ALPN
2$12,095$316.69$11,982$758.21+$113.00ALPN
3← crossover$13,267$325.21$13,526$1,136.44$259.00PEP
4$14,529$333.38$15,727$1,741.93$1.2KPEP
5$15,887$341.21$19,012$2,750.28$3.1KPEP
6$17,348$348.70$24,173$4,514.44$6.8KPEP
7$18,918$355.85$32,789$7,793.80$13.9KPEP
8$20,605$362.67$48,258$14,354.51$27.7KPEP
9$22,417$369.17$78,586$28,686.63$56.2KPEP
10$24,361$375.35$144,688$63,430.49$120.3KPEP

ALPN vs PEP: Complete Analysis 2026

ALPNStock

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Full ALPN Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this ALPN vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALPN vs SCHDALPN vs JEPIALPN vs OALPN vs KOALPN vs MAINALPN vs MOALPN vs PMALPN vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.